64Cu-labeled folate-conjugated shell cross-linked nanoparticles for tumor imaging and radiotherapy: synthesis, radiolabeling, and biologic evaluation.
暂无分享,去创建一个
Kai Qi | J. L. Turner | Dipanjan Pan | Karen L Wooley | Michael J Welch | Xiankai Sun | Raffaella Rossin | M. Welch | K. Wooley | D. Pan | R. Rossin | K. Qi | Xiankai Sun | Jeffrey L Turner
[1] Robert J. Lee,et al. Boron delivery to a murine lung carcinoma using folate receptor-targeted liposomes. , 2002, Anticancer research.
[2] K. Wooley,et al. Determination of the bioavailability of biotin conjugated onto shell cross-linked (SCK) nanoparticles. , 2004, Journal of the American Chemical Society.
[3] V. R. McCready,et al. FDG accumulation and tumor biology. , 1998, Nuclear medicine and biology.
[4] Robert J. Lee,et al. Antitumor Activity of Folate Receptor-Targeted Liposomal Doxorubicin in a KB Oral Carcinoma Murine Xenograft Model , 2003, Pharmaceutical Research.
[5] G. Hardee,et al. Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo. , 2003, Bioconjugate chemistry.
[6] Karen L. Wooley,et al. Shell crosslinked polymer assemblies: Nanoscale constructs inspired from biological systems , 2000 .
[7] Sanyog Jain,et al. Liposomes Modified with Cyclic RGD Peptide for Tumor Targeting , 2004, Journal of drug targeting.
[8] P. Couvreur,et al. Design of folic acid-conjugated nanoparticles for drug targeting. , 2000, Journal of pharmaceutical sciences.
[9] Thommey P. Thomas,et al. In vitro targeting of synthesized antibody-conjugated dendrimer nanoparticles. , 2004, Biomacromolecules.
[10] P. Low,et al. Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[11] J. L. Turner,et al. Shell Cross-Linked Nanoparticles Designed To Target Angiogenic Blood Vessels via αvβ3 Receptor−Ligand Interactions , 2004 .
[12] P. Wils,et al. Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors , 2002, Gene Therapy.
[13] C. Anderson,et al. Production and applications of copper-64 radiopharmaceuticals. , 2004, Methods in enzymology.
[14] Pauline Chu,et al. A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticles. , 2004, International journal of radiation oncology, biology, physics.
[15] M. Bednarski,et al. Vascular-targeted nanoparticles for molecular imaging and therapy. , 2004, Methods in enzymology.
[16] J. L. Turner,et al. Folic acid-conjugated nanostructured materials designed for cancer cell targeting. , 2003, Chemical communications.
[17] J. Reddy,et al. Folate-targeted chemotherapy. , 2004, Advanced drug delivery reviews.
[18] L. Brannon-Peppas,et al. Nanoparticle and targeted systems for cancer therapy. , 2004, Advanced drug delivery reviews.
[19] M J Welch,et al. Efficient production of high specific activity 64Cu using a biomedical cyclotron. , 1997, Nuclear medicine and biology.
[20] P. Saigo,et al. Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein. , 1993, The American journal of pathology.
[21] M. Green,et al. The folate receptor as a molecular target for tumor-selective radionuclide delivery. , 2003, Nuclear medicine and biology.
[22] Samuel Zalipsky,et al. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[23] M. Becker,et al. Peptide-derivatized shell-cross-linked nanoparticles. 1. Synthesis and characterization. , 2004, Bioconjugate chemistry.
[24] Rong Zhou,et al. Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery. , 2004, Academic radiology.
[25] Russell J Mumper,et al. Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[26] P. Couvreur,et al. Nanoparticles in cancer therapy and diagnosis. , 2002, Advanced drug delivery reviews.
[27] L. Munn,et al. Aberrant vascular architecture in tumors and its importance in drug-based therapies. , 2003, Drug discovery today.
[28] R. Jain,et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[29] Gert Storm,et al. Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system , 1995 .
[30] Y. Maitani,et al. Enhanced in vitro DNA transfection efficiency by novel folate-linked nanoparticles in human prostate cancer and oral cancer. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[31] Y. Cheng,et al. Demonstration of a high affinity folate binder in human cell membranes and its characterization in cultured human KB cells. , 1979, The Journal of biological chemistry.
[32] J. Shively,et al. An improved method for conjugating monoclonal antibodies with N-hydroxysulfosuccinimidyl DOTA. , 2001, Bioconjugate chemistry.
[33] A. Antony,et al. Folate receptors. , 1996, Annual review of nutrition.
[34] S M Moghimi,et al. Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.
[35] Rakesh K Jain,et al. Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics , 2002, Science.
[36] M. Bednarski,et al. Tumor Regression by Targeted Gene Delivery to the Neovasculature , 2002, Science.
[37] Samuel Zalipsky,et al. Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates. , 2004, Advanced drug delivery reviews.